Nafady-Hego H - Search Results

1

SARS-CoV-2 infection in mortuary and cemetery workers.

Alishaq M, Jeremijenko A, Nafady-Hego H, Al Ajmi JA, Elgendy M, Fadel RAA, Thomas AG, Alahmed MAA, Ammar A, Bensaad M, Al-Barghouthi B, Coyle P, Elgendy H, Abou-Samra AB, Butt AA. Alishaq M, et al. Int J Infect Dis. 2021 Apr;105:621-625. doi: 10.1016/j.ijid.2021.03.012. Epub 2021 Mar 9. Int J Infect Dis. 2021. PMID: 33711522 Free article.

2

Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience.

Nafady-Hego H, Elgendy H, Moghazy WE, Fukuda K, Uemoto S. Nafady-Hego H, et al. Liver Transpl. 2011 Aug;17(8):976-84. doi: 10.1002/lt.22278. Liver Transpl. 2011. PMID: 21786404 Free article.

3

Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.

Nafady-Hego H, Elgendy H, Uemoto S. Nafady-Hego H, et al. Exp Clin Transplant. 2015 Apr;13 Suppl 1:75-82. Exp Clin Transplant. 2015. PMID: 25894132

4

Outcome of critically-ill children after living-donor liver transplant.

Elgendy H, El Moghazy WM, Nafady-Hego H, Uemoto S. Elgendy H, et al. Exp Clin Transplant. 2015 Apr;13 Suppl 1:100-7. Exp Clin Transplant. 2015. PMID: 25894136

5

Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.

Nafady-Hego H, Elgendy H, Nafady A, Uemoto S. Nafady-Hego H, et al. Exp Clin Transplant. 2016 Apr;14(2):207-14. doi: 10.6002/ect.2015.0206. Epub 2016 Feb 11. Exp Clin Transplant. 2016. PMID: 26867537 Free article.

6

Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.

Nafady-Hego H, Li Y, Ohe H, Elgendy H, Zhao X, Sakaguchi S, Bishop GA, Koshiba T. Nafady-Hego H, et al. Transpl Immunol. 2016 May;36:1-8. doi: 10.1016/j.trim.2016.04.005. Epub 2016 Apr 20. Transpl Immunol. 2016. PMID: 27105585

7

Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study.

Albukhari TAM, Nafady-Hego H, Elgendy H, Abd Elmoneim HM, Nafady A, Alzahrani AM. Albukhari TAM, et al. Int J Microbiol. 2019 Aug 1;2019:6351874. doi: 10.1155/2019/6351874. eCollection 2019. Int J Microbiol. 2019. PMID: 31467552 Free PMC article.

8

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy.

Elgendy H, Nafady-Hego H, Abd Elmoneim HM, Youssef T, Alzahrani A. Elgendy H, et al. Indian J Anaesth. 2019 Oct;63(10):805-813. doi: 10.4103/ija.IJA_324_19. Epub 2019 Oct 10. Indian J Anaesth. 2019. PMID: 31649392 Free PMC article.

9

Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab.

Rashad A, Mousa S, Nafady-Hego H, Nafady A, Elgendy H. Rashad A, et al. Sci Rep. 2021 Apr 23;11(1):8816. doi: 10.1038/s41598-021-88086-x. Sci Rep. 2021. PMID: 33893337 Free PMC article. Clinical Trial.

10

Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.

Jeremijenko A, Chemaitelly H, Ayoub HH, Alishaq M, Abou-Samra AB, Al Ajmi JAAA, Al Ansari NAA, Al Kanaani Z, Al Khal A, Al Kuwari E, Al-Mohammed A, Al Molawi NHA, Al Naomi HM, Butt AA, Coyle P, El Kahlout RA, Gillani I, Kaleeckal AH, Masoodi NA, Thomas AG, Nafady-Hego H, Latif AN, Shaik RM, Younes NBM, Rahim HFA, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R, Abu-Raddad LJ. Jeremijenko A, et al. Emerg Infect Dis. 2021 May;27(5):1343-1352. doi: 10.3201/eid2705.204365. Emerg Infect Dis. 2021. PMID: 33900174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page